I. Meeting Information
The 11th meeting of the 4th Board of Directors of Hangzhou Baicheng Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "the Company") was held on June 1, 2026 (Monday) in the company meeting room, combining in-person and remote attendance. The meeting notice was delivered to all directors via communication on May 29, 2026. A total of 8 directors were required to attend, and all 8 directors were present (of which 4 attended via communication). The meeting was chaired by Ms. Lou Jinfang, and senior management attended. The meeting complied with relevant laws, regulations, and the Company's Articles of Association. After careful deliberation by all directors, the following resolutions were made:
II. Meeting Resolutions
(1) Approval of the Proposal for Nominating Non-Independent Director Candidates
To ensure the normal operation of the Company's Board of Directors, in accordance with the Company Law, Articles of Association, and other relevant regulations, the Board proposed to nominate Mr. Jiang Yide as a candidate for a non-independent director of the 4th Board of Directors, with a term starting from the date of approval at the first extraordinary shareholders' meeting of 2026 until the expiration of the 4th Board of Directors. This proposal has been approved by the 5th meeting of the Nomination Committee of the 4th Board of Directors and requires submission to the shareholders' meeting for approval. Voting results: 8 votes in favor, 0 votes against, 0 abstentions. For details, please refer to the announcement titled "Announcement on the Resignation of Non-Independent Directors and the Election of Non-Independent Directors" disclosed on the Giant Tide Information Network (http://www.cninfo.com.cn) (Announcement No. 2026-020).
(2) Approval of the Proposal for Reappointing Tianjian Accounting Firm
Tianjian Accounting Firm (Special General Partnership) strictly adhered to laws and regulations during its tenure as the Company's auditing institution for the year 2025, diligently and responsibly issuing an independent audit opinion, ensuring the authenticity, accuracy, and completeness of the announcement content for the Company and all members of the Board of Directors, and bearing responsibility for any false records, misleading statements, or significant omissions in the announcement. The audit report objectively and fairly reflected the Company's financial status and operating results, and the Board agreed to continue appointing Tianjian Accounting Firm as the auditing institution for the year 2026. Regarding the audit fees for 2026, the Board will propose to the shareholders' meeting to authorize the management to negotiate the final audit fees with Tianjian Accounting Firm based on the number of auditors required for the annual report audit and the workload involved, as well as the firm's fee standards. Voting results: 8 votes in favor, 0 votes against, 0 abstentions. This proposal has been approved by the 7th meeting of the Audit Committee of the 4th Board of Directors and requires submission to the shareholders' meeting for approval. For details, please refer to the announcement titled "Announcement on the Reappointment of Tianjian Accounting Firm" disclosed on the Giant Tide Information Network (http://www.cninfo.com.cn) (Announcement No. 2026-021).